IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13

drug approval expired 100% Health

A study presented at the Infectious Diseases Society of America’s IDWeek meeting found that starting HPV vaccination at ages 9–10, rather than 11–12, improves initiation and completion rates by age 13. The findings support earlier vaccination to increase coverage among adolescents.

🇺🇸 Location: Washington — Sources: 73 — First seen: — Last seen:
HPV vaccine vaccination adolescents vaccine completion IDWeek

Linked Entities

IDWeek

organization involved

Washington DC

location involved 🇺🇸

Northeast United States

location involved

Harrisburg Patriot-News

organization involved

cabotegravir

organization involved

rilpivirine

organization involved

ProKidney Corp.

organization involved

Rilparencel

organization involved

Zai Lab Limited

organization involved

ZL-1310

organization involved

GLP-1

organization involved 🇺🇸

osteoarthritis

organization involved

U.S. Food and Drug Administration

organization involved

United States

location involved 🌐

E. coli

organization involved 🇺🇸

Eli Lilly

organization involved 🇺🇸

Novo Nordisk

organization involved

Ozempic

organization involved

Medical Xpress

organization involved

retatrutide

organization involved

Acumen Pharmaceuticals

organization involved

Alzheimer's disease

organization involved

Seeking Alpha

organization involved 🌐

Mount Sinai

organization involved

long COVID

organization involved

Kyverna Therapeutics

organization involved

National Football League

organization involved

JAMA Network Open

organization involved

Boston

location involved 🇺🇸

chronic traumatic encephalopathy

organization involved

Saby George

person involved

The Lancet Oncology

organization involved

bevacizumab

organization involved

pazopanib

organization involved

acute lymphoblastic leukemia

organization involved

Mayo Clinic

organization involved

iScience

organization involved

Genmab A/S

organization involved

UC San Francisco

organization involved

diffuse midline glioma

organization involved

CAR-T cells

organization involved

JAMA Internal Medicine

organization involved

American Society of Nephrology

organization involved

Kidney Week

organization involved

Denver

location involved 🇺🇸

HeartBot

organization involved

Yoshimi Fukuoka

person involved

San Francisco

location involved

Ascletis

organization involved

ASC30

organization involved

U.S. Phase II study

organization involved

Coherus Oncology, Inc.

organization involved

Tagmokitug

organization involved

Viking Therapeutics

organization involved

Processa

organization involved

Eloxx

organization involved

B. Riley

organization involved

PDS Biotechnology

organization involved

Kent Nastiuk

person involved

Journal for ImmunoTherapy of Cancer

organization involved

Vertex

organization involved

Food and Drug Administration

organization involved 🇲🇽

Donald Trump

person involved 🌐

Regenstrief Institute

organization involved

Indiana University

organization involved

Purdue University

organization involved 🇺🇸

University of Florida

organization involved 🇺🇸

Geron Corporation

organization involved

IMPACT-MF Study

organization involved

Walmart

organization involved 🇮🇳

Amazon

organization involved 🇺🇸

Genmab

organization involved

Iovance Biotherapeutics, Inc.

organization involved

Lifileucel

organization involved

non-small cell lung cancer

organization involved

Northwestern Medicine

organization involved

Journal of Clinical Investigation

organization involved

Northwestern University

organization involved

Alkermes

organization involved

Cartesian

organization involved

Descartes-08

organization involved

Wu Tsai Neurosciences Institute

organization involved

Aarhus University

organization involved

Eyepoint Pharmaceuticals

organization involved

diabetic macular edema

organization involved

p53

organization involved

Beam Therapeutics Inc.

organization involved

BEAM-301

organization involved

Glycogen storage disease type 1a

organization involved

Aclaris Therapeutics, Inc.

organization involved

ATI-052

organization involved

Aspen

location involved

Parkinson’s disease

organization involved

San Diego

location involved 🇺🇸

Fox Chase Cancer Center

organization involved

anoctamin 6 (ANO6)

organization involved

pancreatic cancer

organization involved

Celcuity

organization involved

vopimetostat

organization involved

Tango Therapeutics

organization involved

ESMO 2026

organization involved

Leão XIV

person involved

Estados Unidos

location involved 🌐

Illinois

location involved 🇺🇸

Igreja Católica

organization involved

NBC

organization involved 🇬🇧

NRx Pharmaceuticals, Inc.

organization involved

ketamine

organization involved

M13 bacteriophage

organization involved

Cambridge

location involved 🇬🇧

Aspen Neuroscience

organization involved

Gilead

organization involved

melanoma

organization involved

Agios Pharmaceuticals

organization involved

FDA

organization involved 🇺🇸

Costco

organization involved

Lowe's

organization involved

Inovio Pharmaceuticals

organization involved

PGN-EDODM1

organization involved

PepGen

organization involved

Wired

organization involved

AI agent

organization involved

Altitude-AD

organization involved

Aura Biosciences

organization involved

Tavneos

organization involved

Ars Technica

organization involved

University of Chicago

organization involved

Cancer Cell

organization involved

TET2

organization involved

Contributing Articles